The National Institute of Health and GC Pharma are struggling with a shortage of blood donations needed for the development a Covid-19 treatment that utilizes antibodies in the plasma.
While various antiviral drugs are being tested for Covid-19 treatment, remdesivir has become the first scientifically proven effective treatment for the new coronavirus.
Korea JoongAng Daily Sitemap